anginal drugs in coronary artery disease - Clinical trials results

Systematic review and meta-analysis of clinical trials about anginal drugs in coronary artery disease.

Clinical trials enrolled the following type of patients :

all type of patients

hemodialysis patients

See also:

anti-anginal drugs (all clinical conditions)
coronary artery disease (all therapeutical action or mecanism)
Other anti-anginal drugs: acebutolol + nifedipine , indur + betablockers , ISMN , ISMN + atenolol , ISMN + beta blocker , ISMN + beta blockers , ISMN + bupranolol , ISMN SR + beta-blockers , ivabradine , ivabradine 10mg , ivabradine 15 mg , ivabradine 15mg , ivabradine 20mg , ivabradine 5mg , nicorandil , nifedipine + metoprolol , nifedipine SR + atenolol , nifedipine SR + metoprolol , nisoldipine + atenolol , nitroglycerin + beta blocker , ranolazine , ranolazine 1000mg , ranolazine 1000mg + amlodipine , trimetazidine + atenolol , trimetazidine + metoprolol , trimetazidine + propranolol ,
anginal drugs in Coronary Artery Disease
anginal drugs in angor
anginal drugs in stable angina
anginal drugs in Coronary Arteriosclerosis
anginal drugs in Coronary Atherosclerosis
anginal drugs in Myocardial Ischemia
anginal drugs in Ischemic Heart Diseases

Entry term : Coronary Artery Disease, angor, stable angina, Coronary Arteriosclerosis, Coronary Atherosclerosis, Myocardial Ischemia, Ischemic Heart Diseases, ,

citeULike

This site complies to the HONcode standard for trustworthy health information: verify here.

Last uptaded on 2010/10
33 user(s) connected

TrialResults-center database by TrialResults-center is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France License .

OpenSearch feed - Add TrialResults-center.org to your browser's search bar